FDA Alerts

The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.

After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.

The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.

The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.

The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.

The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.

After clinical trials demonstrated its safety and efficacy, the FDA approved a new treatment that is the first to combine standard care with a new therapy for adult patients with hyperuricemia associated...

The US Food and Drug Administration granted regular approval to a maintenance therapy for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

The US Food and Drug Administration has approved a new option for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Lorazepam Oral Concentrate has been voluntarily recalled by Amneal Pharmaceuticals.